I have three repeated hormone panels showing low free testosterone, normal total testosterone, and elevated sex hormone‑binding globulin (SHBG) (~60 nmol/L); what does this indicate and how should I evaluate and manage it?

Elevated SHBG with Low Free Testosterone: Evaluation and Management

What This Pattern Indicates

Your repeated hormone panels showing low free testosterone, normal total testosterone, and elevated SHBG (~60 nmol/L) indicate functional hypogonadism due to excessive testosterone binding. 1 This pattern occurs because SHBG binds testosterone tightly, reducing the biologically active (free) fraction even when total testosterone appears normal. 2

The most common causes of elevated SHBG in men not receiving exogenous testosterone include aging, hyperthyroidism, hepatic disease (especially cirrhosis), HIV/AIDS, smoking, and certain medications such as anticonvulsants, estrogens, or thyroid hormone. 2

---

Essential Diagnostic Workup

Confirm True Hypogonadism

• Repeat morning total testosterone (8–10 AM) on at least one additional occasion to confirm persistent levels, as single measurements are insufficient due to diurnal variation and assay variability. 1, 2

• Calculate the free androgen index (FAI) using the formula: (total testosterone ÷ SHBG) × 100. 2 An FAI < 30 confirms true hypogonadism even when total testosterone is borderline-normal. 2

• Measure free testosterone by equilibrium dialysis (gold standard) if available, as direct immunoassays are unreliable when SHBG is abnormal. 2, 3, 4

Differentiate Primary vs. Secondary Hypogonadism

• Measure serum LH and FSH after confirming low testosterone. 1, 2, 5

  • Low or inappropriately normal LH/FSH → secondary (hypothalamic-pituitary) hypogonadism
  • Elevated LH/FSH → primary (testicular) hypogonadism

• This distinction is critical because secondary hypogonadism can be treated with gonadotropin therapy to restore both testosterone production and fertility, whereas primary hypogonadism requires testosterone replacement, which permanently suppresses fertility. 1, 2

Identify Reversible Causes of Elevated SHBG

Before considering testosterone therapy, screen for and address:

• Hyperthyroidism – measure TSH 2
• Hepatic disease/cirrhosis – obtain liver function tests and hepatitis serologies 2
• HIV/AIDS – perform risk-based testing 2
• Medications – review anticonvulsants, estrogens, thyroid hormone 2
• Smoking – counsel cessation 2

Evaluate for Secondary Causes of Hypogonadism

• Measure serum prolactin if LH is low or low-normal, as hyperprolactinemia can cause secondary hypogonadism. 1, 2

• Assess for obesity-related hypogonadism – calculate BMI and waist circumference, as excess adipose tissue increases aromatization of testosterone to estradiol, suppressing LH. 1, 2

• Screen for metabolic syndrome/diabetes – obtain fasting glucose, HbA1c, and lipid profile. 1, 2

• Consider pituitary MRI if testosterone < 150 ng/dL with LH/FSH < 1.5 IU/L, or if prolactin exceeds 1.5 × the upper limit of normal, or if visual field defects or anosmia are present. 2

---

Management Strategy

First-Line: Address Underlying Causes

• For obesity-related secondary hypogonadism: implement a hypocaloric diet (500–750 kcal/day deficit) and structured exercise (≥150 min/week moderate-intensity aerobic activity plus resistance training 2–3 times/week). 1, 2 A 5–10% weight loss can markedly increase endogenous testosterone. 1, 2

• For hyperthyroidism: treat with antithyroid drugs, radioiodine, or surgery. 2

• For hepatic disease: optimize liver function; in cirrhosis, use the free testosterone index (total testosterone ÷ SHBG < 0.3) to define hypogonadism. 2

• For medication-induced SHBG elevation: discontinue or substitute SHBG-elevating drugs when feasible. 2

Pharmacologic Options

If You Desire Fertility Preservation

• Gonadotropin therapy (recombinant hCG + FSH) is mandatory in secondary hypogonadism with fertility concerns. 1, 2 Exogenous testosterone is contraindicated because it causes prolonged azoospermia. 1, 2

• Combined hCG + FSH restores both serum testosterone and spermatogenesis. 1, 2

If You Do Not Desire Fertility

• Testosterone replacement is indicated only after confirming biochemical hypogonadism (two morning testosterone < 300 ng/dL) and the presence of specific symptoms (diminished libido or erectile dysfunction). 1, 2

• Transdermal testosterone gel 1.62% (40 mg daily) is first-line due to stable serum levels and lower risk of erythrocytosis (15.4%) compared with injectables (43.8%). 1, 2

• Intramuscular testosterone cypionate/enanthate 100–200 mg every 2 weeks is a cost-effective alternative but carries higher erythrocytosis risk. 1, 2

• Target mid-normal serum testosterone concentrations (450–600 ng/dL). 1, 2

---

Expected Treatment Outcomes

• Testosterone therapy yields a small but statistically significant improvement in sexual function and libido (standardized mean difference ≈ 0.35). 1, 2

• There is little to no effect on physical functioning, energy, vitality, depressive symptoms, or cognition. 1, 2 The primary therapeutic indication is sexual dysfunction (low libido, erectile dysfunction). 1, 2

• Fatigue, low energy, mood disturbances, and cognitive complaints show minimal or no improvement even with confirmed hypogonadism. 1, 2

---

Monitoring and Safety

Baseline Assessments

• Hematocrit/hemoglobin (absolute contraindication if > 54%) 1, 2
• PSA for men > 40 years (PSA > 4.0 ng/mL requires urologic evaluation and negative prostate biopsy before therapy) 1, 2

Follow-Up Schedule

• 2–3 months after initiation: measure serum testosterone (mid-interval for injectables), hematocrit, and PSA 1, 2
• Every 3–6 months during the first year: repeat testosterone, hematocrit, PSA, lipid profile, and perform digital rectal examination 1, 2
• Annually thereafter: continue the same panel if stable 1, 2

Safety Thresholds

• Withhold testosterone if hematocrit rises > 54%; consider therapeutic phlebotomy in high-risk individuals. 1, 2
• Refer to urology if PSA increases > 1.0 ng/mL within the first 6 months or > 0.4 ng/mL per year thereafter. 1, 2
• Discontinue therapy at 12 months if there is no documented improvement in sexual function. 1, 2

---

Critical Pitfalls to Avoid

• Do not diagnose hypogonadism on a single testosterone measurement or on symptoms alone; require two fasting morning values < 300 ng/dL plus specific sexual symptoms. 1, 2

• Always obtain LH and FSH after confirming low testosterone; the primary vs. secondary distinction guides therapy and fertility counseling. 1, 2

• Never initiate testosterone without confirming the patient does not desire fertility, as exogenous testosterone can cause prolonged azoospermia. 1, 2

• Avoid direct immunoassays for free testosterone in men with abnormal SHBG; use equilibrium dialysis or calculate the free androgen index. 2, 3, 4

• Do not prescribe testosterone for weight loss, general energy enhancement, or athletic performance, as these are not evidence-based indications. 1, 2